SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-22-001779
Filing Date
2022-01-04
Accepted
2022-01-04 16:45:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d278779d424b3.htm 424B3 96280
2 GRAPHIC g278779g01a03.jpg GRAPHIC 32513
  Complete submission text file 0001193125-22-001779.txt   142312
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-261871 | Film No.: 22506857
SIC: 2836 Biological Products, (No Diagnostic Substances)